Vera Therapeutics Vera logo

News Releases

September 9, 2021

Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA Nephropathy

SOUTH SAN FRANCISCO, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing treatments for immunological diseases that improve patients’ lives, announced today that it is scheduled to host a key opinion leader … Read more
August 16, 2021

Vera Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

SOUTH SAN FRANCISCO, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing treatments for immunological diseases that improve patients’ lives, today reported its financial results for the second quarter ended … Read more
July 14, 2021

Vera Therapeutics Appoints Sean Grant as Chief Financial Officer

Healthcare and financial services industry veteran brings nearly 15 years of multi-disciplinary financial experience and proven track record in strategic investments, equity capital markets, and partnerships SOUTH SAN FRANCISCO, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. … Read more
June 24, 2021

Vera Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

Completed an initial public offering with net proceeds, including the exercise of the underwriters’ option in full, of approximately $48.4 million in May 2021 - - - Expanded the management team to support initiation of atacicept clinical development program - - - Initiated Phase 2b ORIGIN clinical … Read more
May 27, 2021

Vera Therapeutics to Participate in the Jefferies Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that management will … Read more
May 13, 2021

Vera Therapeutics Announces Pricing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the pricing of its initial … Read more
April 20, 2021

Vera Therapeutics Appoints Industry Veteran Dr. Celia Lin as Chief Medical Officer

Announces two senior appointments to product development and manufacturing and finance teams   SOUTH SAN FRANCISCO, Calif.,   April 20, 2021  – Vera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with … Read more
January 19, 2021

Vera Therapeutics Launches with $80 Million Series C Financing to Develop Phase 2b Novel Biologic for Kidney Disease

Potential first-in-class disease-modifying biologic in late-stage clinical studies Experienced executive development team from Gilead Sciences   SOUTH SAN FRANCISCO, Calif.,  January 19, 2021 – Vera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for … Read more
Top